Earnings Feed
Start Free
Home/Filings/4/0001415889-25-008551
4//SEC Filing

Yoon Jun 4

Accession 0001415889-25-008551

CIK 0001888886other
View on SEC.govCompany Profile

Filed

Mar 17, 8:00 PM ET

Accepted

Mar 18, 8:45 PM ET

Size

13.8 KB

Accession

0001415889-25-008551

Insider Transaction Report

Form 4
Period: 2025-03-15
Structure Therapeutics Inc.GPCR
Yoon Jun
CHIEF FINANCIAL OFFICER
Transactions
  • Award

    Ordinary Shares

    2025-03-15+170,166→ 1,293,299 total
  • Award

    American Depositary Shares

    2024-11-20+821→ 2,115 total
    → Ordinary Shares (2,463 underlying)
  • Award

    Employee Stock Option (right to buy)

    2025-03-15+413,445→ 413,445 total
    Exercise: $7.02Exp: 2035-03-14→ Ordinary Shares (413,445 underlying)
  • Award

    American Depositary Shares

    2024-05-20+694→ 1,294 total
    → Ordinary Shares (2,082 underlying)
Holdings

  • Ordinary Shares

    (indirect: See footnote)
    1,554,586
Footnotes (8)
  • [F1]The Ordinary Shares of the Issuer may be represented by American Depositary Shares ('ADSs"). Each ADS represents three Ordinary Shares of the Issuer.
  • [F2]Represents the grant of restricted stock units ("RSUs"), each of which represents a contingent right to receive one Ordinary Share of the Issuer. The RSUs vest 1/4th annually on each anniversary of March 1, 2025, subject to Reporting Person's continued service on such dates.
  • [F3]By Jun Sik Yoon and Hayung Yang Yoon, Trustees of The Yoon Family Trust, dated December 11, 2019.
  • [F4]The option exercise price per share is equal to the fair market value per Ordinary Share on the grant date based on the trading price of the Issuer's ADSs.
  • [F5]1/4th of the shares subject to the option shall vest March 1, 2026, and the remaining shares shall vest in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service through each such vesting date.
  • [F6]Each ADS is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The ADSs have no expiration date.
  • [F7]Voluntary reporting of the acquisition of 694 ADSs by the Reporting Person on May 20, 2024 pursuant to the Issuer's Employee Share Purchase Plan.
  • [F8]Voluntary reporting of the acquisition of 821 ADSs by the Reporting Person on Novembery 20, 2024 pursuant to the Issuer's Employee Share Purchase Plan.

Documents

1 file

Issuer

Structure Therapeutics Inc.

CIK 0001888886

→
Entity typeother

Related Parties

1
  • filerCIK 0001962414

Filing Metadata

Form type
4
Filed
Mar 17, 8:00 PM ET
Accepted
Mar 18, 8:45 PM ET
Size
13.8 KB
View on SEC.gov